Ticker
VNDACompany Name
VANDA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 251.72M | $ 0 | $ 0 | 0% |
3/31/2025 | $ 248.7M | $ 0 | $ 0 | 0% |
12/31/2024 | $ 257.76M | $ 0 | $ 0 | 0% |
9/30/2024 | $ 292.71M | $ 0 | $ 0 | 0% |
6/30/2024 | $ 328.75M | $ 0 | $ 0 | 0% |
3/31/2024 | $ 291.57M | $ 0 | $ 0 | 0% |
12/31/2023 | $ 234.18M | $ 0 | $ 0 | 0% |
9/30/2023 | $ 194.46M | $ 605K | $ 0 | -0.31% |
6/30/2023 | $ 341.6M | $ 609K | $ 0 | -0.18% |
3/31/2023 | $ 367.07M | $ 734K | $ 0 | -0.2% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for VANDA PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 6.32M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 601.06M ]
(=) Payout Yield [ -1.05% ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |